Published on in Vol 14 (2026)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/85538, first published
.

Journals
- Katterbauer K, Yılmaz S, Özbay R. AI-Enabled Drug Discovery Platforms: Navigating the Confluence of Software, Medical Device, and Pharmaceutical Regulation in Sino-African Trade Relations. Yildiz Social Science Review 2026;12(1):40 View
- Ali M, Tajwar M, Ahmed F, Hussain M, Wong W, Xiong H. Emerging Trends in Artificial Intelligence‐Driven Drug Discovery: Balancing Chemical Design and Pharmacological Properties for Cancer Therapy. Medicinal Research Reviews 2026 View
- Hu F, Yang H, Cheng J, Huang Z, Yang S, Wang X, Zhou H, Hu J, Hu H, Zhao S. Spatiotemporal evolution of innovation collaboration networks in China’s AI medical device industry: implications for public health governance. Frontiers in Public Health 2026;14 View
- Korabelnikov D, Lamotkin A. Comparative analysis of artificial intelligence-enabled medical devices in the state registries of the USA, China, and Russia. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 2026 View
